Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Skye Bioscience Inc.

    NASDAQ: SKYE · Real-Time Price · USD
    3.33
    -0.06 (-1.77%)
    At close: Aug 19, 2025, 3:59 PM
    3.25
    -2.36%
    After-hours: Aug 19, 2025, 07:03 PM EDT

    Skye Bioscience Balance Sheet Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 68.42M 1.26M 1.24M 8.98M
    Short-Term Investments
    		 n/a n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 53.91K 8.31K 8.31K 8.31K
    Receivables
    		 5.07K 158.24K 74.12K n/a
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 207.21K 9.64M 6.74M 61.44K
    Total Current Assets
    		 70.83M 11.65M 8.94M 9.61M
    Property-Plant & Equipment
    		 1.88M 281.26K 159.04K 234.68K
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 1.94M 289.57K 167.35K 242.99K
    Total Assets
    		 72.76M 11.94M 9.11M 9.86M
    Account Payables
    		 569.25K 1.16M 1.79M 900.01K
    Deferred Revenue
    		 n/a n/a n/a n/a
    Short-Term Debt
    		 182.43K 4.37M 1.9M 1.97M
    Other Current Liabilities
    		 549.15K 7.03M 7.48M 435.57K
    Total Current Liabilities
    		 4.34M 13.9M 12.12M 3.91M
    Long-Term Debt
    		 273.16K n/a n/a n/a
    Other Long-Term Liabilities
    		 n/a n/a n/a n/a
    Total Long-Term Liabilities
    		 273.16K 171.23K n/a 78.7K
    Total Liabilities
    		 4.61M 14.07M 12.12M 3.99M
    Total Debt
    		 455.59K 4.62M 1.98M 2.14M
    Common Stock
    		 30.98K 12.35K 3.65K 476.11K
    Retained Earnings
    		 -130.95M -104.38M -66.74M -47.26M
    Comprehensive Income
    		 n/a n/a n/a n/a
    Shareholders Equity
    		 68.15M -2.13M -3.01M 5.86M
    Total Investments
    		 n/a n/a n/a n/a

    Add to Watchlist